Clinical Trials
- Leukemia
The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. A Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Endocrine System, Genetics
test
- Ages18 years - 60 years
- GenderBoth
- Prostate Cancer
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Ages18 years and older
- GenderMale only
test
- Leukemia, Pediatric Cancers
test
- Sarcoma Cancers, Brain and Other Nervous System Cancers, Other Cancers, Lymphoma, Kidney Cancer, Leukemia, Liver Cancer, Stomach and Esophagus, Thyroid and Other Endocrine Cancers, Gynecological Cancers, Lung Cancer, Bladder Cancer, Colorectal Cancer, Pediatric Cancers
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
- Women's Health, COVID-19 Inpatient, COVID-19 Outpatient
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
- Ages18 years and older
- GenderBoth
- COVID-19 Inpatient, COVID-19 Outpatient
Long Covid: Understanding Immune, Symptom, and Treatment Experiences Nationwide (LISTEN Study)
- Ages18 years and older
- GenderBoth
- COVID-19 Inpatient, COVID-19 Outpatient
Patient response to COVID19 outbreak
- Ages18 years and older
- GenderBoth
Topical Antibacterial Agents for Prevention of COVID-19
- Ages18 years - 60 years
- GenderBoth